Citalopram HBr | CAS 59729-32-7 - Request Quote
Citalopram HBr
| SZ CAT No: | SZ-C039016 |
| CAS No | 59729-32-7 |
| Mol.F. | C20H21FN2O : HBr |
| Mol.Wt. | 324.4 : 80.9 |
| Inv. Status | Under Synthesis |
| Rel. CAS No | 59729-33-8 (free base) ; 85118-27-0 (HCl salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Citalopram HBr is chemically (1RS)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide (as per EP). Citalopram HBr is supplied with detailed characterization data compliant with regulatory guideline. Citalopram HBr can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Citalopram.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 59729-32-7
Purchase 59729-32-7
Order 59729-32-7
Enquire 59729-32-7
price of 59729-32-7
59729-32-7 Supplier
59729-32-7 Manufacturer
59729-32-7 Exporter
buy high quality Citalopram HBr
Purchase Citalopram HBr
Citalopram HBr suppliers
Citalopram HBr manufacturers
Citalopram HBr price
Order Citalopram HBr
Enquire Citalopram HBr
Citalopram HBr cost
Citalopram HBr Supplier
Citalopram HBr Distributor
Citalopram HBr for Method Validation
Citalopram Reference Standard
Citalopram HBr for ANDA Filing
Citalopram HBr for Forced Degradation Studies
Citalopram HBr Identification Standards
Citalopram HBr for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


